Autologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With Myeloma
Clinical trial NCT03448978 · TERMINATED
Trial details
- NCT number
- NCT03448978
- Sponsor
- Cartesian Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-08
- Primary completion
- 2021-04-19
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.